Evolution of dermatomyositis during therapy with a tumor necrosis factor alpha inhibitor

Arthritis Rheum. 2006 Dec 15;55(6):982-4. doi: 10.1002/art.22358.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Biopsy
  • Dermatomyositis / chemically induced*
  • Dermatomyositis / pathology
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / adverse effects*
  • Muscle, Skeletal / pathology
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept